Milana Frenkel-Morgenstern

Has grant

Associate Professor

Country flagIsrael

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Liquid Biopsy for Early Diagnostics of Glioblastoma

Open Date: 2022-10-01

Close Date: 2023-10-01

Grant: Close

Detection of chimeric RNA by novel magnetic system

Open Date: 2021-10-01

Close Date: 2023-10-01

Grant: Close

Developing of Liquid Biopsy platform for arthritis and lupus

Open Date: 2019-10-01

Close Date: 2021-10-01

Grant: Close

Non-invasive Liquid Biopsy for early diagnostics of gliomas

Open Date: 2018-10-01

Close Date: 2019-10-01

Grant: Close

Developing of Liquid Biopsy platform for glioblastoma

Open Date: 2018-09-01

Close Date: 2021-09-01

Articles (14)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

The ongoing COVID-19 pandemic caused by SARS-CoV-2 infections has quickly developed into a global public health threat. COVID-19 patients show distinct clinical features, and in some cases, during the severe stage of the condition, the disease severity leads to an acute respiratory disorder. In spite of several pieces of research in this area, the molecular mechanisms behind the development of disease severity are still not clearly understood. Recent studies demonstrated that SARS-CoV-2 alters the host cell splicing and transcriptional response to overcome the host immune response that provides the virus with favorable conditions to replicate efficiently within the host cells. In several disease conditions, aberrant splicing could lead to the development of novel chimeric transcripts that could promote the functional alternations of the cell. As severe SARS-CoV-2 infection was reported to cause abnormal splicing in the infected cells, we could expect the generation and expression of novel chimeric transcripts. However, no study so far has attempted to check whether novel chimeric transcripts are expressed in severe SARS-CoV-2 infections. In this study, we analyzed several publicly available blood transcriptome datasets of severe COVID-19, mild COVID-19, other severe respiratory viral infected patients, and healthy individuals. We identified 424 severe COVID-19 -specific chimeric transcripts, 42 of which were recurrent. Further, we detected 189 chimeric transcripts common to severe COVID-19 and multiple severe respiratory viral infections. Pathway and gene enrichment analysis of the parental genes of these two subsets of chimeric transcripts reveals that these are potentially involved in immune-related processes, interferon signaling, and inflammatory responses, which signify their potential association with immune dysfunction leading to the development of disease severity. Our study provides the first detailed expression landscape of chimeric transcripts in severe COVID-19 and other severe respiratory viral infections.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Aviram Mizrachi

sackler faculty of medicine tel aviv university tel aviv israel

ISRAEL
View details

Dan Yaniv

Head of the Head and Neck Research Lab

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Yong Chen

Prof

Rowan University

UNITED STATES
View details